Published in Blood Weekly, October 11th, 2001
"Enumerating and phenotyping of platelets, resting and activated, from whole blood is important for both the identification and verification of many disease states," according to Tim L. Wyant and colleagues at SurroMed, Inc., a biotechnology firm in Mountain View, California.
MLSC testing can accurately and simultaneously determine the quantity and characteristics of platelets in blood samples containing platelet-inhibiting anticoagulants, Wyant and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.